[Tamoxifen and early-stage breast cancer: meta-analysis of randomized trials]

Cancer Radiother. 1999 Jul-Aug;3(4):341. doi: 10.1016/s1278-3218(99)80077-8.

[Article in French]

Authors

M A Proudhom¹, G Noël, J J Mazeron

Affiliation

¹ Centre des tumeurs, hôpital de la Pitié-Salpêtrière, Paris, France.

PMID: 10486546
DOI: 10.1016/s1278-3218(99)80077-8

No abstract available

Publication types

Meta-Analysis

MeSH terms

Adult
Aged
Antineoplastic Agents, Hormonal / therapeutic use*
Breast Neoplasms / drug therapy*
Breast Neoplasms / mortality
Breast Neoplasms / pathology
Carcinoma / drug therapy*
Carcinoma / mortality
Carcinoma / pathology
Female
Humans
Middle Aged
Neoplasm Proteins / analysis
Neoplasm Recurrence, Local / epidemiology
Neoplasms, Hormone-Dependent / drug therapy
Neoplasms, Second Primary / epidemiology
Randomized Controlled Trials as Topic
Receptors, Estrogen / analysis
Survival Analysis
Tamoxifen / therapeutic use*
Treatment Outcome

Substances

Antineoplastic Agents, Hormonal
Neoplasm Proteins
Receptors, Estrogen
Tamoxifen